Literature DB >> 20573581

Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization.

Yu Hong Li1, ShengFu Huang, MinQuan Du, Zhuan Bian, Zhi Chen, Ming Wen Fan.   

Abstract

Mucosal immune responses act as the first line of defense against dental caries. In this study, an optimal vaccination strategy was developed to enhance anti-caries mucosal immune responses. Mice and rats were vaccinated intranasally firstly with plasmid pCIA-P encoding PAc antigen of Streptococcus mutans and then with rPAc, or with pCIA-P for twice, or with rPAc protein for twice, respectively. The potential of inducing mucosal and systemic immune responses to special antigens was measured by ELISA. In addition, antibody type, cytokine production and protection effectiveness against dental caries were also evaluated. Although all immunized groups developed immune responses, the antibody responses in the DNA prime-protein boost group were stronger compared with those elicited by either the DNA vaccine or the protein vaccine. In particular, the Th1-biased response that was established by the DNA immunization was diverted to Th1/Th2-mixed response following the rPAc protein boost. Moreover, protection against S. mutans challenge was obtained in the rats treated with the DNA prime-protein boost regimen, as shown by a significant reduction in dental caries lesion, compared with the control groups immunized with the DNA or protein only. All these findings may provide useful information about effective mucosal vaccines against dental caries. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573581     DOI: 10.1016/j.vaccine.2010.04.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Anti-caries DNA vaccine-induced secretory immunoglobulin A antibodies inhibit formation of Streptococcus mutans biofilms in vitro.

Authors:  Li Huang; Qing-an Xu; Chang Liu; Ming-wen Fan; Yu-hong Li
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

3.  Co-delivery of ccl19 gene enhances anti-caries DNA vaccine pCIA-P immunogenicity in mice by increasing dendritic cell migration to secondary lymphoid tissues.

Authors:  Yan-hong Yan; Sheng-cai Qi; Ling-kai Su; Qing-an Xu; Ming-wen Fan
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

4.  Intranasal co-delivery of IL-6 gene enhances the immunogenicity of anti-caries DNA vaccine.

Authors:  Ling-kai Su; Fei Yu; Zhao-fei Li; Chang Zeng; Qing-an Xu; Ming-wen Fan
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

5.  The Combinations Chitosan-Pam3CSK4 and Chitosan-Monophosphoryl Lipid A: Promising Immune-Enhancing Adjuvants for Anticaries Vaccine PAc.

Authors:  Yongli Bi; Qingan Xu; Lingkai Su; Jiantao Xu; Zhongfang Liu; Ying Yang; Hua Tang; Yuhong Li; Mingwen Fan
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

6.  Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets.

Authors:  Amorsolo L Suguitan; Xing Cheng; Weijia Wang; Shixia Wang; Hong Jin; Shan Lu
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

7.  Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening.

Authors:  Fen Liu; Xueliang Wang; Mei Zheng; Feifei Xiong; Xueying Liu; Linting Zhou; Wensong Tan; Ze Chen
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

8.  Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model.

Authors:  Jyoti Gupta; Manisha Pathak; Sweta Misra; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.